Unexplained Pauses in Centers for Disease Control and Prevention Surveillance: Erosion of the Public Evidence Base for Health Policy

Overview

The study documents systematic pauses in CDC public health surveillance databases as of October 2025, examining the scope and characteristics of interruptions in real-time data updates that support clinical and policy decision-making. The audit identified databases previously maintained on monthly schedules that have ceased or substantially delayed updates, with particular concentration among vaccination-related surveillance systems.

Methods and approach

A comprehensive audit of the CDC public data catalog was conducted on 28 October 2025, identifying 1,359 catalog records. Eighty-two databases with prior monthly update frequency were selected for analysis. Classification as current or paused was determined by comparing the stated periodicity plus a 30-day grace period against the most recent data entry date. Temporal characteristics of paused databases were evaluated, including time since last update and topic domain. Persistence of pauses was reassessed on 2 December 2025.

Results

Of 82 databases examined, 44 (54%) were current and 38 (46%) were paused. Among paused databases, 34 (89%) had no updates within 6 months of analysis. Vaccination-related databases comprised 33 of 38 paused systems (87%), with no paused vaccination databases present in the current category. Five paused databases addressed other topics: four covering respiratory disease burden and nonvaccine prevention measures, and one addressing drug overdose mortality. Follow-up assessment on 2 December 2025 revealed only one paused database had resumed updates.

Implications

The extended and unexplained pauses in surveillance data represent a substantive disruption to the evidence base available to clinicians, health administrators, professional organizations, and policymakers for clinical guidance development and health policy formulation. The concentration of pauses within vaccination-related surveillance raises particular concerns regarding the timeliness and transparency of disease prevention program data. The minimal resumption of paused databases within a 5-week window suggests systematic rather than operational factors affecting data availability.